Encompass Health Corporation (NYSE: EHC) reported Q1 EPS of $0.88, $0.18 better than the analyst estimate of $0.70. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.14 billion.

GUIDANCE:

Encompass Health Corporation sees FY2023 EPS of $2.94-$3.23, versus the consensus of $3.08. Encompass Health Corporation sees FY2023 revenue of $4.7-4.77 billion, versus the consensus of $4.72 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.